IncFact
Company Profiles: Revenue, Growth, Competition

ANCORA HEART Revenue, Growth & Competitor Profile

DBA GUIDED DELIVERY SYSTEMS, INC.
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Ancora Heart

Access the complete profile.

Ancora Heart Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes33911
Address2355 Calle De Luna
Santa Clara, CA 95054

www.gdsmed.com
Note: Revenues for privately held companies are statistical evaluations.


Ancora Heart's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry.


Ancora Heart's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Ancora Heart Annual Revenue and Growth Rate

Ancora Heart Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Ancora Heart's revenues are gauged from an analysis of company filings.



Investor Activity

Ancora Heart has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
December 28, 2018 5 67%$35 MM
Complete list of funding rounds and total amounts in the Company Report




Ancora Heart's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Ancora Heart Revenue (Sales) Ancora Heart Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Ancora Heart is developing and marketing. Ancora Heart doesn't have any recent trademark applications, indicating Ancora Heart is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
BASAL VENTRICULOPLASTY
Medical and surgical catheters; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for preventing or reversing heart failure; Medical apparatus for treating congestive heart failure; Medical devices for treating congestive heart failure
06/25/2013
SMARTCINCH
Medical devices for use in cardiac remodeling and repair, namely, implants consisting of artificial matter, anchors, cables, and catheters; surgical apparatuses used to deliver cardiac implants for use in cardiac remodeling and repair; medical catheters used to deliver cardiac implants for use in cardiac remodeling and repair
09/29/2009

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Ancora Heart grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Ancora Heart is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Ancora Heart's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ancora Heart, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
HANDICARE USAMaryland Heights, MO100 
GAUMARD SCIENTIFICMiami, FL69 
SHL PHARMADeerfield Beach, FL29 
FIRST NATION GROUPNiceville, FL26 
MD24Surprise, AZ14 
PRYTIME MEDICAL DEVICESLakewood, CO12 
BIODERMLargo, FL11 
ALLIANCE PARTNERSSan Antonio, TX8 
IN2BONES USAMemphis, TN6 




Nearby Competitors

These companies are similar in business line and location to Ancora Heart. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
SI-BONESanta Clara, CA100 
STELLARTECH RESEARCHMilpitas, CA52 
MIRAMAR LABSSanta Clara, CA28 
CAPSO VISIONSaratoga, CA26 
ELIXIR MEDICALMilpitas, CA24 
PHOENIX DE VENTURESMorgan Hill, CA22 




Future Competition: Ancora Heart's Fastest Growing Competitors

These companies are in the same general field as Ancora Heart and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Ancora Heart Competitors